Physician profile
James Mooney
NPI 1831621226
$93,301.08
in general payments reported to CMS, 2019-2025
10 companies · $40K in 2025
The $40K reported for 2025 was more than what 94% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $487 · 2024: $53K · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $88K · Food and Beverage: $3,472 · Travel and Lodging: $1,481 · Education: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $87,500.00 |
| Food and Beverage | $3,472.24 |
| Travel and Lodging | $1,481.24 |
| Education | $360.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $52,551.23 | 2022-2025 | Cd Horizon Spinal System, Mazor X System, Unid_pass |
| Arthrex, INC. | $37,613.00 | 2025 | |
| Synthes Gmbh | $931.87 | 2024 | |
| Globus Medical, INC. | $636.58 | 2024-2025 | Creo Addition, Xlif, Reline |
| Depuy Synthes Sales INC. | $573.31 | 2024-2025 | Symphony, Velys, Fibergraft Aeridyan Matrix |
| Stryker Corporation | $381.61 | 2022-2024 | |
| Kuros Biosciences USA, INC | $238.46 | 2025 | Magnetos |
| Spineology INC. | $169.32 | 2024 | Optimesh Expandable Interbody Fusion System |
| Bioventus LLC | $146.50 | 2025 | |
| Fortis Surgical, LLC | $59.20 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mooney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.